NEWS
LyonBioTech, a Technological Research Institute has been selected
LyonBioTech is proposing a totally new public/private partnership model, based on an integrated, interdisciplinary approach to R&D aiming to promote innovation in the study and treatment of infectious diseases, for the benefit of patients.
An ambitious Technological Research Institute for a comprehensive and personalized management of infectious diseases
LyonBioTech will focus its action on economic and industrial development. Its aim is to anchor healthcare industries in the region and to foster the emergence of MSE’s in promising sectors of the future, while responding to public health challenges related to infectious diseases
(14 million deaths/year caused by infectious diseases).
A Technological Research Institute aiming to become an internationally renowned campus, creating values and jobs
Within 10 years, LyonBioTech has an objective to create 10,000 direct and indirect jobs, in order to reach a critical mass and to obtain an international visibility. The budget of the LyonBioTech TRI is estimated at more than €700 million over a period of 9 years. About 5,000 sq. m (54,000 sq. ft) of real estate dedicated to the TRI, out of a total of 30,000 to 40,000 sq. m (up to 400,000 sq. ft) in the long run, should be available soon at the sites of Lyon Gerland and Institut Pasteur Paris.
